Tyler Mouw, MD
Surgical Oncology · Lubbock, TXNPI 1588058499
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (43.1%), education and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Intuitive Surgical at 42.1% of the total.
Across 35 payments — averaging $146.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Histosonics, Inc.$2K
- Pacira Pharmaceuticals Incorporated$261
- Innovation Technologies Inc$147
- Organogenesis Inc.$139
- AbbVie$112
- plus $307 from 9 others
What the payments were for
- Travel & lodging$2,20343%
- Food & beverage$1,40928%
- Education$1,50029%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 4 | $2,153 |
| Histosonics, Inc. | 2 | $1,993 |
| Pacira Pharmaceuticals Incorporated | 3 | $261 |
| Innovation Technologies Inc | 2 | $147 |
| Organogenesis Inc. | 1 | $139 |
| AbbVie | 7 | $112 |
| Smith+Nephew | 5 | $79 |
| Angiodynamics, Inc. | 3 | $60 |
| Stryker | 1 | $48 |
| Amgen | 1 | $28 |
| Merck | 2 | $27 |
| Lifenet Health | 1 | $20 |
| W. L. Gore & Associates, Inc. | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Boston Scientific | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$1,500
- Da Vinci Surgical System$634
- EXPAREL$240
- PURAPLY WOUND MATRIX$139
- Irrisept$129
How this compares
$5,112 in reported general payments places this provider in the 70th percentile of 191 surgical oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in Lubbock
- Allison DipasqualeDallas$272K
- Merrick RossHouston$216K
- John HardawayShenandoah$164K
- Steven CurleyTyler$162K
- Suhail SharifFort Worth$137K
- Alfredo Santillan GomezSan Antonio$125K
- Kelly HuntHouston$104K
- Adam YoppDallas$96K
- Peter BeitschDallas$62K
- Patricio PolancoDallas$61K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.